Induced pluripotent stem cell-derived mesenchymal stem cells

1 paper5 findings

In a bleomycin-induced mouse model, induced pluripotent stem cell-derived mesenchymal stem cells reduce skin collagen density and dermal thickness and improve skin vascularisation. Cell and mouse experiments come from one lab, funded by the Chinese Academy of Medical Sciences, National Natural Science Foundation of China, Peking Union Medical College and Peking Union Medical College Hospital.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Funders: Chinese Academy of Medical Sciences and 3 more

Animals1

Outcomes

Angiogenesis

upin mouse cells1

1 study

Induced pluripotent stem cell-derived mesenchymal stem cells increase angiogenesis in mouse cells.
Cells
MSCs derived from ADSC-reprogrammed iPSCs exhibit enhanced therapeutic potential for treating skin fibrosis
Stem cells translational medicine18 Aug 2026

Latest

1 in 12 months

Stem Cells Translational Medicine1 Sep

MSCs derived from ADSC-reprogrammed iPSCs exhibit enhanced therapeutic potential for treating skin fibrosis

Experiments in miceSkin

Paper

Induced pluripotent stem cell-derived mesenchymal stem cells

Outcomes

Latest

MSCs derived from ADSC-reprogrammed iPSCs exhibit enhanced therapeutic potential for treating skin fibrosis

Related